The North America Granisetron Market is progressing as healthcare providers adopt antiemetic therapies to improve patient outcomes during chemotherapy and postoperative recovery. Increasing investment in cancer care, the availability of prescription medications, and greater awareness of treatment-related side effects are supporting demand across hospitals and specialty treatment centers....